SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 3.57 |
Enterprise Value ($M) | 0.77 |
Book Value ($M) | -2.21 |
Book Value / Share | -1.51 |
Price / Book | -1.62 |
NCAV ($M) | -3.54 |
NCAV / Share | -2.42 |
Price / NCAV | -1.01 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -0.89 |
Return on Equity (ROE) | -1.94 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.58 |
Current Ratio | 0.58 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 4.83 |
Assets | 6.17 |
Liabilities | 8.37 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.42 |
Operating Income | -25.45 |
Net Income | -22.55 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -16.11 |
Cash from Investing | -0.01 |
Cash from Financing | 0.85 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Dellora Investments LP | 0.00 | -100.00 | |
13G/A | Schonfeld Strategic Advisors LLC | 0.18 | -99.75 | |
13G/A | Altium Capital Management LP | 4.99 | -53.70 | |
13G/A | Acorn Bioventures, L.p. | 0.00 | -100.00 | |
13G | Lind Global Fund II LP | 9.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1) | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,439 | 49,666 | 4.91 | |
40,768 | 159,085 | 25.63 | |
53,740 | 233,827 | 22.98 | |
68,923 | 387,564 | 17.78 | |
(click for more detail) |
Similar Companies | |
---|---|
CTXR – Citius Pharmaceuticals, Inc. | CUE – Cue Biopharma, Inc. |
CVKD – Cadrenal Therapeutics, Inc. | CYCN – Cyclerion Therapeutics, Inc. |
CYRX – Cryoport, Inc. |